Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 1087, pseudogene** (RNU6-1087P) is a **pseudogene derived from the U6 small nuclear RNA (snRNA)** gene family. U6 snRNA is an essential component of the spliceosome, a ribonucleoprotein complex responsible for splicing introns from pre-mRNA in eukaryotic cells[1][3]. However, pseudogenes such as RNU6-1087P are **non-functional genetic elements** that originate by duplication or retrotransposition of the parent U6 snRNA gene, and they do **not produce functional RNA or protein products**[2][5]. Pseudogenes can be present in large copy numbers in the genome and serve as markers of retrotransposition activity, but **RNU6-1087P itself does not possess biological activity, does not participate in cellular pathways, disease roles, or therapeutic targeting**[2][5]. **Key notes:** - This entity is a non-coding RNA pseudogene and **not a functional gene, receptor, enzyme, or typical therapeutic target**[2][5]. - There is nothing obviously incorrect about the name or identification, but it is **not a therapeutic or druggable target** and has no documented roles in disease or as a biomarker. - U6 pseudogenes like RNU6-1087P reflect the evolutionary history and retrotranspositional dynamics of the genome but have **no direct biological or pathological function**[2][5]. If you require structured information specifically about the functional U6 snRNA (rather than the pseudogene), that can be provided upon request.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1087, pseudogene (RNU6-1087P).